Galera Therapeutics enters retention bonus agreement with CAO Joel Sussman for up to $250,000

Galera Therapeutics, Inc.

Up to $250,000 in retention bonuses tied to timely completion and filing of reporting obligations.
Retention payments reduce severance payments under existing employment agreement dollar-for-dollar.
Unpaid bonus accelerates if involuntary termination (not for cause) or good reason occurs.
Agreement dated February 6, 2026, with payments tied to specific conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.